Literature DB >> 31676722

An Emerging Regulatory Role for the Tumor Microenvironment in the DNA Damage Response to Double-Strand Breaks.

Tshering D Lama-Sherpa1, Lalita A Shevde2,3.   

Abstract

Radiation, alkylating agents, and platinum-based chemotherapy treatments eliminate cancer cells through the induction of excessive DNA damage. The resultant DNA damage challenges the cancer cell's DNA repair capacity. Among the different types of DNA damage induced in cells, double-strand breaks (DSB) are the most lethal if left unrepaired. Unrepaired DSBs in tumor cells exacerbate existing gene deletions, chromosome losses and rearrangements, and aberrant features that characteristically enable tumor progression, metastasis, and drug resistance. Tumor microenvironmental factors like hypoxia, inflammation, cellular metabolism, and the immune system profoundly influence DSB repair mechanisms. Here, we put into context the role of the microenvironment in governing DSB repair mechanisms. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31676722      PMCID: PMC7002210          DOI: 10.1158/1541-7786.MCR-19-0665

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  103 in total

1.  Human CtIP promotes DNA end resection.

Authors:  Alessandro A Sartori; Claudia Lukas; Julia Coates; Martin Mistrik; Shuang Fu; Jiri Bartek; Richard Baer; Jiri Lukas; Stephen P Jackson
Journal:  Nature       Date:  2007-10-28       Impact factor: 49.962

2.  Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.

Authors:  Zhao-Hui Wu; Yuling Shi; Randal S Tibbetts; Shigeki Miyamoto
Journal:  Science       Date:  2006-02-24       Impact factor: 47.728

Review 3.  The MRE11-RAD50-NBS1 Complex Conducts the Orchestration of Damage Signaling and Outcomes to Stress in DNA Replication and Repair.

Authors:  Aleem Syed; John A Tainer
Journal:  Annu Rev Biochem       Date:  2018-04-25       Impact factor: 23.643

4.  The DNA damage response induces IFN.

Authors:  Sabrina Brzostek-Racine; Chris Gordon; Sarah Van Scoy; Nancy C Reich
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

5.  Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.

Authors:  M Yoneyama; W Suhara; Y Fukuhara; M Fukuda; E Nishida; T Fujita
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

Review 6.  Eukaryotic Mismatch Repair in Relation to DNA Replication.

Authors:  Thomas A Kunkel; Dorothy A Erie
Journal:  Annu Rev Genet       Date:  2015       Impact factor: 16.830

7.  Alterations in DNA repair gene expression under hypoxia: elucidating the mechanisms of hypoxia-induced genetic instability.

Authors:  Ranjit S Bindra; Paul J Schaffer; Alice Meng; Jennifer Woo; Kårstein Måseide; Matt E Roth; Paul Lizardi; David W Hedley; Robert G Bristow; Peter M Glazer
Journal:  Ann N Y Acad Sci       Date:  2005-11       Impact factor: 5.691

Review 8.  Olaparib in the management of ovarian cancer.

Authors:  Kristin Bixel; John L Hays
Journal:  Pharmgenomics Pers Med       Date:  2015-08-07

9.  Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.

Authors:  Kyle C Strickland; Brooke E Howitt; Sachet A Shukla; Scott Rodig; Lauren L Ritterhouse; Joyce F Liu; Judy E Garber; Dipanjan Chowdhury; Catherine J Wu; Alan D D'Andrea; Ursula A Matulonis; Panagiotis A Konstantinopoulos
Journal:  Oncotarget       Date:  2016-03-22

Review 10.  The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases.

Authors:  Hor-Yue Tan; Ning Wang; Sha Li; Ming Hong; Xuanbin Wang; Yibin Feng
Journal:  Oxid Med Cell Longev       Date:  2016-04-06       Impact factor: 6.543

View more
  10 in total

Review 1.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

Review 2.  Unboxing the molecular modalities of mutagens in cancer.

Authors:  Smita Kumari; Sudhanshu Sharma; Dia Advani; Akanksha Khosla; Pravir Kumar; Rashmi K Ambasta
Journal:  Environ Sci Pollut Res Int       Date:  2021-10-05       Impact factor: 5.190

Review 3.  Overcoming Chemotherapy Resistance in Germ Cell Tumors.

Authors:  Zuzana Országhová; Katarina Kalavska; Michal Mego; Michal Chovanec
Journal:  Biomedicines       Date:  2022-04-22

4.  Translation of DNA Damage Response Inhibitors as Chemoradiation Sensitizers From the Laboratory to the Clinic.

Authors:  Leslie A Parsels; Qiang Zhang; David Karnak; Joshua D Parsels; Kwok Lam; Henning Willers; Michael D Green; Alnawaz Rehemtulla; Theodore S Lawrence; Meredith A Morgan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-08-01       Impact factor: 7.038

5.  Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors.

Authors:  Naoko Takebe; Abdul Rafeh Naqash; Geraldine O'Sullivan Coyne; Shivaani Kummar; Khanh Do; Ashley Bruns; Lamin Juwara; Jennifer Zlott; Larry Rubinstein; Richard Piekarz; Elad Sharon; Howard Streicher; Arjun Mittra; Sarah B Miller; Jiuping Ji; Deborah Wilsker; Robert J Kinders; Ralph E Parchment; Li Chen; Ting-Chia Chang; Biswajit Das; Ganesh Mugundu; James H Doroshow; Alice P Chen
Journal:  Clin Cancer Res       Date:  2021-04-16       Impact factor: 13.801

Review 6.  DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment.

Authors:  Takayuki Saitoh; Tsukasa Oda
Journal:  Cancers (Basel)       Date:  2021-01-28       Impact factor: 6.639

7.  DNA-PK inhibition by M3814 enhances chemosensitivity in non-small cell lung cancer.

Authors:  Manni Wang; Siyuan Chen; Yuquan Wei; Xiawei Wei
Journal:  Acta Pharm Sin B       Date:  2021-08-04       Impact factor: 11.413

8.  Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer.

Authors:  Meike Kohlruss; Marie Krenauer; Bianca Grosser; Nicole Pfarr; Moritz Jesinghaus; Julia Slotta-Huspenina; Alexander Novotny; Alexander Hapfelmeier; Thomas Schmidt; Katja Steiger; Matthias M Gaida; Magdalena Reiche; Lukas Bauer; Katja Ott; Wilko Weichert; Gisela Keller
Journal:  Br J Cancer       Date:  2021-10-20       Impact factor: 7.640

Review 9.  Properties of flavonoids in the treatment of bladder cancer (Review).

Authors:  Yue Lv; Zhonghao Liu; Haixing Jia; Youcheng Xiu; Zan Liu; Leihong Deng
Journal:  Exp Ther Med       Date:  2022-09-19       Impact factor: 2.751

Review 10.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.